Going Down - Recensione dipendente - Financial Analyst II presso ICON

2,0
22 set 2025
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Managers are generally nice. Solid entry point into Pharma Finance. Good exposure to different types of work.

Svantaggi

Pay does not make sense in Dublin. Endless outsourcing to India with a drop in quality of work. Just look at the stock price. Company is losing clients and it does not look like a turnaround is in the cards. Merger between LPRA and ICON has been a disaster. It has left two companies weaker than either one was separate.

Esplora altre recensioni su ICON

5,0
19 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Really great manager. Remote work major plus. No micro management. Great pay

Svantaggi

Annual salary increase this year isn't until September which is odd.

4,0
30 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Strong Leadership, Fair/Average compensation, Thrive Program (company strives to keep you employeed as Sponsor reallocations occur)

Svantaggi

HR is very hands off. It is very difficult to speak to anyone. Not simple to call and ask a question. Everything has to go through a portal. This is challenging when there is time sensitive needs. They make it work but in my opinion, this is a 'con'.

Vedi recensioni per: Utile|Valutazione|Data|Tutto